Evidence map›Paper›PMID 26836265›Full record

ArticlePloS one2016

Association of Forced Vital Capacity with the Developmental Gene NCOR2.

Cosetta Minelli, Charlotte H Dean, Matthew Hind, Alexessander Couto Alves, André F S Amaral, Valerie Siroux, Ville Huikari, María Soler Artigas, David M Evans, Daan W Loth and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Fat-soluble Vitamins and Lung Cancer: Where We Are?Recent patents on anti-cancer drug discovery · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Lung Development Genes and Adult Lung Function.American journal of respiratory and critical care medicine · 2020
    Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 6 countries.

Cosetta MinelliRespiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Charlotte H DeanLeukocyte Biology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Matthew HindRespiratory Department, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Alexessander Couto AlvesDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
André F S AmaralRespiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Valerie SirouxUniv. Grenoble Alpes, IAB, Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, F-38000, Grenoble, France.
Ville HuikariBiocenter Oulu, University of Oulu, Oulu, Finland.
María Soler ArtigasGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
David M EvansUniversity of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
Daan W LothDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Yohan BosséInstitut universitaire de cardiologie et de pneumologie de Québec, Department of Molecular Medicine, Laval University, Québec, Canada.
Dirkje S PostmaDepartment of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Don SinThe University of British Columbia Center for Heart Lung Innovation, St-Paul's Hospital, Vancouver, Canada.
John ThompsonDepartment of Health Sciences, University of Leicester, Leicester, United Kingdom.
Florence DemenaisINSERM, UMRS-946, Genetic Variation of Human Diseases Unit, Paris, France.
John HendersonSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
SpiroMeta consortium
CHARGE consortium
Emmanuelle BouzigonINSERM, UMRS-946, Genetic Variation of Human Diseases Unit, Paris, France.
Deborah JarvisRespiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Marjo-Riitta JärvelinDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Peter BurneyRespiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Inserm · FRMRC Centre for Environment and HealthImperial College London · GBUniversity of Leicester · GBErasmus MC · NLInstitut universitaire de cardiologie et de pneumologie de Québec · CAMary Lyon Centre at MRC Harwell · GBOulu University Hospital · FIRoyal Brompton & Harefield NHS Foundation Trust · GBTranslational Research Institute · AUUniversity Medical Center Groningen · NLUniversity of Bristol · GBUniversity of British Columbia · CAUniversity of Oulu · FI

Funding

CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Genetics of cardiovascular risk factors in large founder population birth controlR01HL087679 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HIRSCHHORN, JOEL N · 2007 to 2009
$4.0M
Genetic Influences on ADHD in a Finnish Birth CohortR01MH063706 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SMALLEY, SUSAN L · 2001 to 2005
$3.3M
Whole Genome Assoc. Analysis Strategies for Multi. PhenotypesRL1MH083268 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B. · 2007 to 2011
$2.1M
Basal Ganglia and 5-HT in Ritualistic Social DisplaysR01MH062633 · NIMH · UNIVERSITY OF FLORIDA · PI BAXTER, LEWIS R · 2001 to 2005
$1.4M
Chief Scientist Office CZD/16/6/4Medical Research Council G0600705Medical Research Council G0901214Medical Research Council G1000861Medical Research Council G1002319Medical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_U106179471Medical Research Council MC_UU_12013/4Medical Research Council MC_UU_12015/1Medical Research Council MR/M022501/1NHLBI NIH HHS R01 HL087679NHLBI NIH HHS R01 HL105756NIMH NIH HHS R01 MH062633NIMH NIH HHS R01 MH063706NIMH NIH HHS RL1 MH083268Wellcome Trust 102215
6 · The paper itself

Abstract

backgroundForced Vital Capacity (FVC) is an important predictor of all-cause mortality in the absence of chronic respiratory conditions. Epidemiological evidence highlights the role of early life factors on adult FVC, pointing to environmental exposures and genes affecting lung development as risk factors for low FVC later in life. Although highly heritable, a small number of genes have been found associated with FVC, and we aimed at identifying further genetic variants by focusing on lung development genes.

methodsPer-allele effects of 24,728 SNPs in 403 genes involved in lung development were tested in 7,749 adults from three studies (NFBC1966, ECRHS, EGEA). The most significant SNP for the top 25 genes was followed-up in 46,103 adults (CHARGE and SpiroMeta consortia) and 5,062 children (ALSPAC). Associations were considered replicated if the replication p-value survived Bonferroni correction (p<0.002; 0.05/25), with a nominal p-value considered as suggestive evidence. For SNPs with evidence of replication, effects on the expression levels of nearby genes in lung tissue were tested in 1,111 lung samples (Lung eQTL consortium), with further functional investigation performed using public epigenomic profiling data (ENCODE).

resultsNCOR2-rs12708369 showed strong replication in children (p = 0.0002), with replication unavailable in adults due to low imputation quality. This intronic variant is in a strong transcriptional enhancer element in lung fibroblasts, but its eQTL effects could not be tested due to low imputation quality in the eQTL dataset. SERPINE2-rs6754561 replicated at nominal level in both adults (p = 0.036) and children (p = 0.045), while WNT16-rs2707469 replicated at nominal level only in adults (p = 0.026). The eQTL analyses showed association of WNT16-rs2707469 with expression levels of the nearby gene CPED1. We found no statistically significant eQTL effects for SERPINE2-rs6754561.

conclusionsWe have identified a new gene, NCOR2, in the retinoic acid signalling pathway pointing to a role of vitamin A metabolism in the regulation of FVC. Our findings also support SERPINE2, a COPD gene with weak previous evidence of association with FVC, and suggest WNT16 as a further promising candidate.

Indexed as

Genes, DevelopmentalGenetic Association StudiesAdultAgedFemaleForced Expiratory VolumeGene Expression ProfilingGenome-Wide Association StudyHumansLungMaleMiddle AgedNuclear Receptor Co-Repressor 2OrganogenesisPolymorphism, Single NucleotideQuantitative Trait LociNuclear Receptor Co-Repressor 2

Identifiers

PMID26836265
PMCPMC4737618
OpenAlexW2267267340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.